Heads of big pharmaceuticals, ‘It is possible for any company to become next Hanmi’
Would it be possible for a company to continue the Hanmi Pharm’s success in technology export? According to general managers of Asia-Pacific Open Innovation Platform, such as CEOs at Sanofi and Roche, the possibility is highly expected.
Persons concerned to global big pharmaceuticals said, “The...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
